Virbagest 4mg/ml Oral Suspension for Pigs
Country: Romania
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
03-09-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
altrenogest 4 mg
Available from:
Virbac S.A.
ATC code:
QG03DX90
Pharmaceutical form:
Oral solution
Therapeutic group:
Altrenogest
Therapeutic area:
Pigs
Authorization date:
2009-05-27
Summary of Product characteristics
Revised: December 2012
AN. 01534/2011
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
VIRBAGEST 4 mg/ml oral solution for pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Altrenogest
4.00 mg/ml
EXCIPIENTS:
Butylhydroxytoluene (E321) 0.07 mg/ml
Butylhydroxyanisole (E320) 0.07 mg/ml
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral solution for top-dressing use.
Clear, slightly yellow solution.
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs (nulliparous mature sows).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the synchronisation of oestrus in nulliparous mature sows.
4.3 CONTRAINDICATIONS
Do not use in boars.
Do not administer to pregnant sows (see section 4.7) or those suffering from uterine
infection.
Do not use in case of hypersensitivity to the active substance.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Revised: December 2012
AN. 01534/2011
Page 2 of 5
Ensure the correct dose is administered daily as under dosing can lead to the formation
of cystic follicles.
Add the veterinary medicinal product to the feed immediately before feeding. Discard
any uneaten medicated feed.
Use only in sexually mature gilts that have been in oestrus.
Part consumed feed must be safely disposed of and not given to any other animal.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY
MEDICINAL PRODUCT TO ANIMALS
Women who are pregnant, or
Read the complete document
